ArticleJournal of clinical medicine2026
Beyond Malignancy: Clinical Insights from Three Cases of Severe Hypercalcemia.
Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe hypercalcemia is a life-threatening condition requiring immediate treatment alongside a systematic evaluation to identify the underlying cause. Although malignancy is a common etiology among hospitalized patients, alternative causes must be considered to guide targeted therapy, as illustrated in these cases. The first case involved a 31-year-old postpartum woman with corrected calcium levels of 14.5 mg/dL and suppressed PTH. Hypercalcemia resolved after tapering and temporary cessation of breastfeeding, consistent with lactation-associated hypercalcemia that is likely PTHrP-mediated. The second case describes a 30-year-old woman who presented with hypotension, hypercalcemia, hyperphosphatemia, and low PTH. A systematic evaluation revealed severe glucocorticoid deficiency consistent with primary adrenal insufficiency (Addison's disease). The final case featured a 47-year-old man with severe symptomatic hypercalcemia (18.5 mg/dL) and markedly elevated PTH. Imaging revealed a 3 cm parathyroid tumor. Selective parathyroidectomy produced a rapid intraoperative PTH decline, and pathology supported parathyroid adenoma rather than carcinoma. Together, these cases highlight that symptomatic severe hypercalcemia is a medical emergency warranting prompt clinical intervention, followed by an early PTH-based stratification to direct a focused, stepwise diagnostic workup and definitive management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.